Fred B. Craves, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 26,500 shares at $1.81 ($50K) on 2008-12-18, disclosed to the SEC on 2008-12-19.
Open-market purchase of $50k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.81 | 616 | $1K | 2.2% |
| 2 | $1.89 | 384 | $726 | 1.4% |
| 3 | $1.90 | 24,350 | $46K | 92.0% |
| 4 | $1.91 | 100 | $191 | 0.4% |
| 5 | $1.91 | 800 | $2K | 3.0% |
| 6 | $1.92 | 250 |
| $480 |
| 1.0% |
| Total | $1.90 avg | 26,500 | $50K | 100% |
| Filing → |
| MDGL | SELL | 2024-11-27 | $1.2M | — | Filing → |
| MDGL | SELL | 2024-05-16 | $9.3M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |